In addition, RSKs are found to phosphorylate cell cycle checkpoint components such as checkpoint kinase 1 (Chk1) and Mer11 to suppress DNA damage signaling and possibly increase cancer cell chemoresistance [61,62]. The gene discussed is CHEK1; the disease is cancer.